Market Tracker

03/23 7:57am ET

IDEXX Laboratories Inc (NASDAQ:IDXX)

152.88
Delayed Data
As of Mar 22
 +2.77 / +1.85%
Today’s Change
74.48
Today|||52-Week Range
153.95
+30.37%
Year-to-Date
MedTech Long-Term Prospects Impress: Which Stocks to Buy?
Mar 22 / Zacks.com - Paid Partner Content
Cooper Companies (COO) Receives ISO 15189 Accreditation
Mar 09 / Zacks.com - Paid Partner Content
3 Medical Device Stocks to Brave Policy Uncertainty
Mar 16 / Zacks.com - Paid Partner Content
C. R. Bard (BCR) Well Poised for Growth, Macro Woes Remain
Mar 09 / Zacks.com - Paid Partner Content
IDEXX (IDXX) Poised on Strong Fundamentals, Innovations
Mar 15 / Zacks.com - Paid Partner Content
Baxter (BAX) Hits a 52-Week High: What's Driving the Stock?
Mar 09 / Zacks.com - Paid Partner Content
ABIOMED Impella Heart Pump Reduces Kidney Injury during PCI
Mar 13 / Zacks.com - Paid Partner Content
Intersect ENT: FDA Submission of RESOLVE Implant, Stock Up
Mar 09 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close150.11
Today’s open152.22
Day’s range150.56 - 153.94
Volume618,481
Average volume (3 months)915,479
Market cap$13.5B
Dividend yield--
Data as of 03/22/2017

Growth & Valuation

Earnings growth (last year)+19.02%
Earnings growth (this year)+20.46%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+10.83%
P/E ratio62.7
Price/Sales6.00
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ALRAlere Inc-0.26-0.68%
NEOGNeogen Corp-1.08-1.65%
AAAPAdvanced Accelerator...+0.31+0.84%
MYGNMyriad Genetics Inc+0.28+1.48%
Data as of 03/22/2017

Financials

Next reporting dateApril 28, 2017
EPS forecast (this quarter)$0.62
Annual revenue (last year)$1.8B
Annual profit (last year)$222.0M
Net profit margin12.51%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Jonathan W. Ayers
Chief Financial Officer, Treasurer &
Executive VP
Brian P. McKeon
Corporate headquarters
Westbrook, Maine

Forecasts